Defence Therapeutics Inc.
DTC
Rank in Stocks
#29533
Headquartered in Vancouver, Canada, Defence Therapeutics Inc. is a... Headquartered in Vancouver, Canada, Defence Therapeutics Inc. is a biotechnology company founded in 2017. This firm focuses on pioneering biological and biosimilar therapeutic solutions for both cancer and infectious diseases. A cornerstone of its approach is the exclusive ACCUM™ technology, engineered to precisely and safely transport vaccine antigens or antibody-drug conjugates (ADCs) directly to their intended cellular targets. The company's development efforts span several key areas: novel dendritic cell vaccines for various cancers, protein-based vaccines addressing COVID-19 and other infectious ailments, and specialized antibody-drug conjugate products aimed at different cancer types. Defence Therapeutics Inc. adopted its current name in March 2020, having previously operated as Accum Therapeutics Inc.
Share Price
$0.25964327
Market Cap
$19.68M
Change (1 day)
0.00%
Change (1 year)
-55.64%
Country
CA
Trade Defence Therapeutics Inc. (DTC)
Category
Healthcare
Stock price history for Defence Therapeutics Inc. (DTC)
Highest end of day price: $0.27 on 2026-10-01
Lowest end of day price: $2.50 on 2021-05-01
Lowest end of day price: $2.50 on 2021-05-01
Stock price history of Defence Therapeutics Inc. from 2021 to 2026
Annual Stock Price Performance
| Year | Performance |
|---|---|
| 2026 (TTM) | -27.55% |
| 2025 | 58.71% |
| 2024 | -79.59% |
| 2023 | -28.12% |
| 2022 | -37.44% |
| 2021 | 0.00% |
Stock price for similar companies or competitors
| Company | Stock price | Change 1y% | Country |
|---|---|---|---|
| $520.06 | 22.00% |
US
|
|
| $249.65 | 808.13% |
US
|
|
| $138.33 | -3.31% |
AU
|
|
| $887.09 | 6.27% |
NL
|
|
| $752.87 | 7.40% |
CH
|
